Clinical trials
Primary Immunodeficiency Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ADMA Biologics, Inc. | 2 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2 |
| University of South Florida | 2 |
| ASIS Corporation | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Azidus Brasil | 1 |
| Beijing Children's Hospital | 1 |
| CHU de Reims | 1 |
| Children's Hospital of Fudan University | 1 |
| Chulalongkorn University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Immunodeficiency Diseases | 31 |
| Genetic Diseases, Inborn | 3 |
| Immune System Diseases | 3 |
| Immunologic Deficiency Syndromes | 3 |
| Anemia, Aplastic | 2 |
| Communicable Diseases | 2 |
| Graft vs Host Disease | 2 |
| Histiocytosis | 2 |
| Lymphohistiocytosis, Hemophagocytic | 2 |
| Lymphoma | 2 |
Trials
Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.